Illumina are a global leader in genomics – an industry at the intersection of biology and technology.

At the most fundamental level, Illumina enable their customers to read and understand genetic variations. They strive to make their solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

Illumina’s goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for them to deliver innovative, flexible, and scalable solutions to meet the needs of their customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, they strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.